Lawrence Bonne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lawrence Bonne has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
Geert Maleux
Department of Radiology, University Hospitals Leuven, Leuven, Belgium
11 shared publications- Geert Maleux
KU Leuven University Hospitals Leuven Gasthuisberg Campus, Belgium
8 shared publications - Jo Peluso
Division of Neuroradiology, Department of Radiology (J.P.P.), University Hospitals Leuven, Belgium
7 shared publications - Wim Laleman
Department of Internal Medicine B, University Hospital Münster, Münster, Germany
6 shared publications - Annouschka Laenen
Center of Biostatics and Statistical Bioinformatics, KU Leuven, Leuven, Belgium
4 shared publications Chris Verslype
Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium
4 shared publications
Latest Publications
- Open Access
- 9 September 2026
- Published by Springer Nature in CVIR Oncology
- Vol. 2 (1) , 23
Effect of balloon-occlusion microcatheters on tumor targeting in holmium-166 radioembolization: a within-patient comparative study
Balloon occlusion microcatheters (BOC) have been proposed to improve tumor targeting during transarterial radioembolization (TARE), but supporting data remain limited. In this exploratory, within-patient study, seven patients undergoing holmium-166 ( 166 Ho) TARE received paired 166 Ho-scout injections via a conventional end-hole catheter (CEHC) and a BOC at identical arterial positions. Tumor-to-normal liver uptake ratio (TNR) was quantified on SPECT/CT, and liver perfusion territories (LPT) were assessed on cone-beam CT. BOC was associated with lower TNRs in six of seven patients (geometric mean ratio 0.41; p = 0.06, not significant) and frequently with reduced LPTs (7–60%) and incomplete tumor coverage. In one patient, higher TNR with BOC coincided with reduced tumor coverage. These findings suggest variable effects of BOC on tumor targeting in 166 Ho-scout work-up and warrant further investigation. Level of evidence: Level 3; prospective within-patient comparative study.
- 9 September 2026
- Published by Springer Nature in CVIR Oncology
- Vol. 2 (1) , 23
Open AccessEffect of balloon-occlusion microcatheters on tumor targeting in holmium-166 radioembolization: a within-patient comparative study
Balloon occlusion microcatheters (BOC) have been proposed to improve tumor targeting during transarterial radioembolization (TARE), but supporting data remain limited. In this exploratory, within-patient study, seven patients undergoing holmium-166 ( 166 Ho) TARE received paired 166 Ho-scout injections via a conventional end-hole catheter (CEHC) and a BOC at identical arterial positions. Tumor-to-normal liver uptake ratio (TNR) was quantified on SPECT/CT, and liver perfusion territories (LPT) were assessed on cone-beam CT. BOC was associated with lower TNRs in six of seven patients (geometric mean ratio 0.41; p = 0.06, not significant) and frequently with reduced LPTs (7–60%) and incomplete tumor coverage. In one patient, higher TNR with BOC coincided with reduced tumor coverage. These findings suggest variable effects of BOC on tumor targeting in 166 Ho-scout work-up and warrant further investigation. Level of evidence: Level 3; prospective within-patient comparative study.
- 20 April 2026
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (3) , 449-462
Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis
- 20 April 2026
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (3) , 449-462
Single-nucleus profiling reveals hepatocyte identity and immune features associated with corticosteroid response in severe alcohol-related hepatitis
- Open Access
- 1 January 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 73 (1) , 432-441
Patient-Inspired In Vitro and CFD Modeling of Hepatic Intraarterial Microballoon Interventions
Objective: While microballoon interventions (MBIs) have emerged as a safe treatment for hepatocellular carcinoma, they also lead to blood flow alterations that are not well understood and could decrease the treatment's effectiveness. In this study, we developed patient-inspired in vitro and in silico models (IVM and ISM). The IVM was used to study the influence of using a microballoon vs. a standard catheter on the tumor targeting and to validate the ISM; the ISM was used to study the influence of the size of a communicating arcade on the tumor targeting. Methods: Two IVM (with a literature-based collateral artery and without collateral artery), two catheter modes (a microballoon catheter with inflated and deflated balloon), and three occlusion locations were combined to conduct an experimental, parametric analysis. Furthermore, the ISM was validated and used to study four collateral artery diameters. Results: The IVM generated realistic hemodynamic alterations, and the ISM replicated the experimental results with an average difference of 4 percent points on the flow distribution per outlet. The designed collateral artery did not affect the simulated intervention negatively. Conclusion: Patient-inspired IVMs and ISMs can be used to better understand the complex hemodynamic phenomena after balloon occlusion and help determine collateral artery sizes that generate successful MBIs. Significance: Combined patient-inspired IVM and ISM of the hepatic artery hemodynamics during MBIs were developed for the first time. This modeling approach could potentially lead to a better assessment of patients with liver cancer not eligible for standard chemoembolization or radioembolization.
- 1 January 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 73 (1) , 432-441
Open AccessPatient-Inspired In Vitro and CFD Modeling of Hepatic Intraarterial Microballoon Interventions
Objective: While microballoon interventions (MBIs) have emerged as a safe treatment for hepatocellular carcinoma, they also lead to blood flow alterations that are not well understood and could decrease the treatment's effectiveness. In this study, we developed patient-inspired in vitro and in silico models (IVM and ISM). The IVM was used to study the influence of using a microballoon vs. a standard catheter on the tumor targeting and to validate the ISM; the ISM was used to study the influence of the size of a communicating arcade on the tumor targeting. Methods: Two IVM (with a literature-based collateral artery and without collateral artery), two catheter modes (a microballoon catheter with inflated and deflated balloon), and three occlusion locations were combined to conduct an experimental, parametric analysis. Furthermore, the ISM was validated and used to study four collateral artery diameters. Results: The IVM generated realistic hemodynamic alterations, and the ISM replicated the experimental results with an average difference of 4 percent points on the flow distribution per outlet. The designed collateral artery did not affect the simulated intervention negatively. Conclusion: Patient-inspired IVMs and ISMs can be used to better understand the complex hemodynamic phenomena after balloon occlusion and help determine collateral artery sizes that generate successful MBIs. Significance: Combined patient-inspired IVM and ISM of the hepatic artery hemodynamics during MBIs were developed for the first time. This modeling approach could potentially lead to a better assessment of patients with liver cancer not eligible for standard chemoembolization or radioembolization.
- 6 October 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (11) , 1625-1631
Efficacy of an X-Ray Protective Drape in Reducing Operator Radiation Dose in Transfemoral Arterial Liver Interventions: a Randomized-Controlled Trial
Purpose Interventional radiologists are among the healthcare professionals most exposed to ionizing scatter radiation. A 0.5 mm lead equivalent X-ray protective drape (MXPD, Mavig, Germany) was introduced to reduce operator radiation dose and has demonstrated efficacy during cardiac interventions. This study evaluates the efficacy of the MXPD during transfemoral liver interventions. Materials & Methods A single-center randomized controlled study was conducted to compare operator radiation exposure during transfemoral liver interventions (n = 100) with and without the MXPD. Primary outcome was the ratio of the combined operator radiation dose values—measured at the chest, eyes and both hands and normalized to the respective dose area products – between MXPD and control groups. Secondary outcomes included the ratios in operator radiation doses measured for the individual dosimeter locations. Results The MXPD group showed a significantly lower normalized radiation dose per DAP (mean reduction 0.31 µSv; 95% CI 0.083–0.536, p = 0.009), representing a 43% reduction. The effect of the drape was the highest for the whole-body dose measured above the lead apron (55% reduction, p = 0.10), the left hand finger dose (43%, p = 0.20) and the eye lens dose estimated at the left temple (63%, p = 0.10) and in between the eyes (47%, p = 0.10). Conclusion The MXPD can effectively reduce operator radiation dose during transfemoral arterial liver interventions, offering a practical adjunct to standard protective measures. Level of Evidence Level 1b, Randomized Controlled Trial. Graphical Abstract
- 6 October 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (11) , 1625-1631
Efficacy of an X-Ray Protective Drape in Reducing Operator Radiation Dose in Transfemoral Arterial Liver Interventions: a Randomized-Controlled Trial
Purpose Interventional radiologists are among the healthcare professionals most exposed to ionizing scatter radiation. A 0.5 mm lead equivalent X-ray protective drape (MXPD, Mavig, Germany) was introduced to reduce operator radiation dose and has demonstrated efficacy during cardiac interventions. This study evaluates the efficacy of the MXPD during transfemoral liver interventions. Materials & Methods A single-center randomized controlled study was conducted to compare operator radiation exposure during transfemoral liver interventions (n = 100) with and without the MXPD. Primary outcome was the ratio of the combined operator radiation dose values—measured at the chest, eyes and both hands and normalized to the respective dose area products – between MXPD and control groups. Secondary outcomes included the ratios in operator radiation doses measured for the individual dosimeter locations. Results The MXPD group showed a significantly lower normalized radiation dose per DAP (mean reduction 0.31 µSv; 95% CI 0.083–0.536, p = 0.009), representing a 43% reduction. The effect of the drape was the highest for the whole-body dose measured above the lead apron (55% reduction, p = 0.10), the left hand finger dose (43%, p = 0.20) and the eye lens dose estimated at the left temple (63%, p = 0.10) and in between the eyes (47%, p = 0.10). Conclusion The MXPD can effectively reduce operator radiation dose during transfemoral arterial liver interventions, offering a practical adjunct to standard protective measures. Level of Evidence Level 1b, Randomized Controlled Trial. Graphical Abstract
- Open Access
- 29 May 2025
- Published by Elsevier in JHEP Reports
- Vol. 7 (8) , 101466
Endoscopic ultrasound-guided portosystemic pressure gradient measurement vs. transjugular balloon occlusion measurement in patients with cirrhosis (ENCOUNTER): A bicentric EU study
- 29 May 2025
- Published by Elsevier in JHEP Reports
- Vol. 7 (8) , 101466
Open AccessEndoscopic ultrasound-guided portosystemic pressure gradient measurement vs. transjugular balloon occlusion measurement in patients with cirrhosis (ENCOUNTER): A bicentric EU study
- 2 January 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (4) , 723-726
Type II Endoleak–Related Contained Aortic Rupture Treated by Emergent Translumbar Glue Embolization
- 2 January 2025
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (4) , 723-726
Type II Endoleak–Related Contained Aortic Rupture Treated by Emergent Translumbar Glue Embolization
- 25 December 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (5) , 713
Three Floating Thrombi in the Aortic Arch
- 25 December 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 69 (5) , 713
Three Floating Thrombi in the Aortic Arch
- 30 October 2024
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (2) , 549-557
Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality
- 30 October 2024
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (2) , 549-557
Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality
- 28 October 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (2) , 282-292
Resin-Based Yttrium-90 Radioembolization as a Bridging or Downstaging Treatment to Liver Transplantation for Hepatocellular Carcinoma
- 28 October 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (2) , 282-292
Resin-Based Yttrium-90 Radioembolization as a Bridging or Downstaging Treatment to Liver Transplantation for Hepatocellular Carcinoma